 |
|
|
| |
Temporal Order of Resistance Emergence for Lamivudine/Emtricitabine, Efavirenz, and Raltegravir in Treatment-Naïve Patients
|
| |
| |
Reported by Jules Levin
International HIV and Hepatitis Drug Resistance Workshop, June 8-12, 2010, Dubrovnik. Croatia
M Miller1, S Fransen2, W Huang2, M Markowitz3, J Lennox4, J Zhao1, P Sklar1, Randi Leavitt1, H Teppler1, B-Y Nguyen1, C Petropoulos2, D Hazuda1
1Merck & Co. Inc., West Point, PA. 2Monogram Biosciences, Inc., South San Francisco, CA. 3Aaron Diamond Research Center, The Rockefeller University, New York, New York. 4Emory University School of Medicine, Atlanta, Georgia.
May be overestimated-1 untested intervening time point
May be overestimated-2 untested intervening time points
|
| |
|
|
|
|
|
